EUVIMEDEUVIMED entdecken
Fallbericht

Possible NAT ‐negative transfusion‐transmitted Babesia microti

Courtney Hopkins, Christopher Gresens, Sara Bakhtary, Ralph Vassallo iD

Transfusion · 2025

DOI: 10.1111/trf.18431 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transfusion, 2025. Verfasst von Courtney Hopkins und 3 weiteren Autor:innen. Beteiligte Einrichtung: Corporate Medical Affairs, Vitalant, Medical Affairs, Scottsdale, Arizona, USA. Hauptthemen laut MEDLINE: Babesia microti, Babesiosis, Blood Donors, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Vitalant operations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of transfusion‐transmitted babesiosis (TTB) has declined substantially in recent years following the introduction of geographically selective nucleic acid testing (NAT) by blood collectors. This approach has proven quite effective in interdicting parasite‐infected units from US regions where Babesia is endemic and is complemented by donor screening questions about prior diagnosis (used in lieu of NAT in non‐ Babesia ‐endemic states). Despite these successes, however, breakthrough cases continue to occur due to limitations in the current geographically targeted testing strategy. Case Report Herein, we report a Minnesota donor reinstated almost 3.5 years after a Babesia NAT‐positive donation whose first post‐reinstatement donation tested NAT‐negative. Three months later, a subsequent donation tested NAT‐positive for Babesia microti . Notification of the hospital that transfused the NAT‐negative red blood cell unit revealed a likely B. microti transmission.

Discussion

This reverse‐notification TTB case was unlikely to have been the result of either a product from an asymptomatic untested donor from a non‐endemic state infected during travel to an endemic area or a tick‐borne infection of the transfusion recipient. More likely, TTB resulted from transfusion of a NAT‐negative unit donated 3 months prior to the involved donor's subsequent NAT‐positive collection. To our knowledge, this is the first reported potential Babesia NAT failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Babesia microtiBabesiosisBlood DonorsNucleic Acid Amplification TechniquesTransfusion ReactionAdultHumansMaleDNA, Protozoan

Stichwörter der Autor:innen

donorsinfectious disease testingtransfusion‐transmitted disease—other

Substanzen

DNA, Protozoan

Autor:innen und Institutionen

  • Corporate Medical Affairs, Vitalant, Medical Affairs, Scottsdale, Arizona, USA.
  • West Division Medical Affairs, Vitalant, West Division, Sacramento, California, USA.
  • Department of Laboratory Medicine, UCSF, San Francisco, California, USA.

ORCID-Profile: Ralph Vassallo

Förderung

  • Vitalant operations

Zitieren

APA

Hopkins, C., Gresens, C., Bakhtary, S., & Vassallo, R. (2025). Possible NAT ‐negative transfusion‐transmitted Babesia microti. Transfusion. https://doi.org/10.1111/trf.18431

Vancouver

Hopkins C, Gresens C, Bakhtary S, Vassallo R. Possible NAT ‐negative transfusion‐transmitted Babesia microti. Transfusion. 2025. doi:10.1111/trf.18431

BibTeX
@article{Hopkins2025,
  author = {Hopkins, Courtney and Gresens, Christopher and Bakhtary, Sara and Vassallo, Ralph},
  title = {Possible NAT ‐negative transfusion‐transmitted Babesia microti},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18431}
}
Kostenlos starten →